ID
38259
Description
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the Pharmacogenetic research consent and withdrawal of consent form.
Lien
https://clinicaltrials.gov/ct2/show/NCT00833989
Mots-clés
Versions (2)
- 05/10/19 05/10/19 -
- 11/10/19 11/10/19 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
5 ottobre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, NCT00833989
Pharmacogenetic research consent and withdrawal of consent
- StudyEvent: ODM
Description
PGx - Pharmacogenetic research consent
Alias
- UMLS CUI-1
- C0021430 (Informed Consent)
- UMLS CUI-2
- C2347500 (Pharmacogenetic Test)
Description
If you tick Yes, please fill in the Date informed consent obtained for PGx-Pharmacogenetic research and if a blood sample has been collected in the following items. If you tick No, please check the reason in the item "No informed consent obtained for PGx, reason".
Type de données
text
Alias
- UMLS CUI [1,1]
- C0021430 (Informed Consent)
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0021430 (Informed Consent)
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
- UMLS CUI [1,3]
- C0011008 (Date in time)
- SNOMED
- 410671006
Description
If you tick Yes, please record the date sample taken in the following item.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0005834 (Collection of blood specimen for laboratory procedure)
- SNOMED
- 82078001
- LOINC
- LP125037-4
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
Description
No informed consent obtained for PGx, reason
Type de données
text
Alias
- UMLS CUI [1,1]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,2]
- C1298908 (no)
- SNOMED
- 373067005
- UMLS CUI [1,3]
- C0021430 (Informed Consent)
- UMLS CUI [1,4]
- C2347500 (Pharmacogenetic Test)
Description
Other reason for no informed consent obtaining
Type de données
text
Alias
- UMLS CUI [1,1]
- C0205394 (Other)
- SNOMED
- 74964007
- LOINC
- LP21049-9
- UMLS CUI [1,2]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,3]
- C0021430 (Informed Consent)
- UMLS CUI [1,4]
- C2347500 (Pharmacogenetic Test)
- UMLS CUI [1,5]
- C1882120 (Not Obtained)
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C1302413 (Specimen collection date)
- SNOMED
- 399445004
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
Description
Pharmacogenetic research withdrawal of consent
Alias
- UMLS CUI-1
- C1707492 (Consent Withdrawn)
- UMLS CUI-2
- C2347500 (Pharmacogenetic Test)
Description
If you tick Yes, please note the date of informed consent withdrawn in the following item.
Type de données
text
Alias
- UMLS CUI [1,1]
- C1707492 (Consent Withdrawn)
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C1707492 (Consent Withdrawn)
- UMLS CUI [1,2]
- C2347500 (Pharmacogenetic Test)
- UMLS CUI [1,3]
- C0011008 (Date in time)
- SNOMED
- 410671006
Description
If you tick Yes, please check reason in the following item.
Type de données
text
Alias
- UMLS CUI [1,1]
- C1272683 (Request - action)
- SNOMED
- 385644000
- UMLS CUI [1,2]
- C1948029 (Destruction (action))
- UMLS CUI [1,3]
- C0178913 (Blood specimen)
- SNOMED
- 119297000
Description
Reason for request for sample destruction
Type de données
text
Alias
- UMLS CUI [1,1]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,2]
- C1272683 (Request - action)
- SNOMED
- 385644000
- UMLS CUI [1,3]
- C1948029 (Destruction (action))
- UMLS CUI [1,4]
- C0178913 (Blood specimen)
- SNOMED
- 119297000
Similar models
Pharmacogenetic research consent and withdrawal of consent
- StudyEvent: ODM
C2347500 (UMLS CUI-2)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,4])
C1882120 (UMLS CUI [1,5])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI-2)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,4])
Aucun commentaire